Condition-specific coaching and care AI
Twin Health
Twin Health combines sensor-based guidance and clinical care with employer and health-plan contracts. Patient authority when personal goals differ from program cost or medication-reduction goals remains unclear. Current policy documents correction rights and a separate clinical-data notice.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 58 out of 100 toward patient-directed
AI digital-twin metabolic care program with a clinical team and employer/plan contracts, not a standalone patient chatbot.
Mixed, potentially agency-expanding
Twin Health combines sensor-based guidance and clinical care with employer and health-plan contracts. Patient authority when personal goals differ from program cost or medication-reduction goals remains unclear. Current policy documents correction rights and a separate clinical-data notice.
Patient agency
How this tool changes agency
Personal data and daily feedback can support reflection. Clinical outcome studies do not establish the ability to inspect a model recommendation or negotiate its objective.
Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified
Patient agency assessment
Who sets and changes the goal?
Members receive individualized guidance, but the public pages do not establish how they can retain a preferred treatment goal when it differs from program cost or medication-reduction targets.
What can the patient understand, question, or do?
Personal data and daily feedback can support reflection. Clinical outcome studies do not establish the ability to inspect a model recommendation or negotiate its objective.
Can the patient evaluate the conditions of use?
The current policy adds concrete correction rights and a separate clinical-data scope. It does not support a blanket claim that all identifiable health data is shared with employers.
Text findings
Conditions of use
Published controls and their limits
The current policy adds concrete correction rights and a separate clinical-data scope. It does not support a blanket claim that all identifiable health data is shared with employers.
What remains unknown?
Not tested or not established
Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Individual sponsor reporting, clinical notice details, recommendation explanations and care-plan negotiation remain unverified No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Moderate for program and policy statements (AI-assisted draft)